Literature DB >> 21291532

A case report of male breast cancer in a very young patient: what is changing?

Marcelo Madeira1, André Mattar, Rodrigo José Barata Passos, Caroline Dornelles Mora, Luiz Henrique Beralde Vilar Mamede, Viviane Hatsumi Kishino, Thomas Zurga Markus Torres, Andressa Fernandes Rodrigues de Sá, Roberto Euzébio dos Santos, Luiz Henrique Gebrim.   

Abstract

Male breast cancer accounts for 1% of all breast cancer cases, and men tend to be diagnosed at an older age than women (mean age is about 67 years). Several risk factors have been identified, such as genetic and hormonal abnormalities. The present study reported the case of a 25-year-old man who was diagnosed with an advanced invasive ductal carcinoma; however, he did not have any important risk factors. Even though more data is emerging about this disease, more efforts to understand risk factors, treatment options and survival benefits are needed. In this case, we discussed the risk factors as well as the impaired fertility associated with breast cancer therapies.

Entities:  

Mesh:

Year:  2011        PMID: 21291532      PMCID: PMC3039618          DOI: 10.1186/1477-7819-9-16

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  28 in total

1.  Breast cancer in a trans-sexual man receiving hormone replacement therapy.

Authors:  I Ganly; E W Taylor
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

2.  Mammography of the male breast.

Authors:  P K Chantra; G J So; J S Wollman; L W Bassett
Journal:  AJR Am J Roentgenol       Date:  1995-04       Impact factor: 3.959

3.  Cancer of the breast in a male cirrhotic: is there an association between the two?

Authors:  S P Misra; V Misra; M Dwivedi
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

Review 4.  Male breast cancer.

Authors:  César Gómez-Raposo; Francisco Zambrana Tévar; María Sereno Moyano; Miriam López Gómez; Enrique Casado
Journal:  Cancer Treat Rev       Date:  2010-03-02       Impact factor: 12.111

5.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Authors:  Thomas S Frank; Amie M Deffenbaugh; Julia E Reid; Mark Hulick; Brian E Ward; Beth Lingenfelter; Kathi L Gumpper; Thomas Scholl; Sean V Tavtigian; Dmitry R Pruss; Gregory C Critchfield
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

6.  Male breast cancer: clinico-pathological features, immunocytochemical characteristics and prognosis.

Authors:  D M Bruce; S D Heys; S Payne; I D Miller; O Eremin
Journal:  Eur J Surg Oncol       Date:  1996-02       Impact factor: 4.424

Review 7.  Male breast cancer: a special therapeutic problem. Anything new? (Review).

Authors:  Roberto Gennari; Giuseppe Curigliano; Barbara A Jereczek-Fossa; Stefano Zurrida; Giuseppe Renne; Mattia Intra; Viviana Galimberti; Alberto Luini; Roberto Orecchia; Giuseppe Viale; Aron Goldhrisch; Umberto Veronesi
Journal:  Int J Oncol       Date:  2004-03       Impact factor: 5.650

8.  Breast carcinoma in men: a population-based study.

Authors:  Sharon H Giordano; Deborah S Cohen; Aman U Buzdar; George Perkins; Gabriel N Hortobagyi
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

9.  Is male breast cancer similar or different than female breast cancer?

Authors:  William F Anderson; Michelle D Althuis; Louise A Brinton; Susan S Devesa
Journal:  Breast Cancer Res Treat       Date:  2004-01       Impact factor: 4.872

10.  Contralateral breast cancer: annual incidence and risk parameters.

Authors:  P Broët; A de la Rochefordière; S M Scholl; A Fourquet; V Mosseri; J C Durand; P Pouillart; B Asselain
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

View more
  5 in total

Review 1.  Nanoparticle-mediated targeted drug delivery for breast cancer treatment.

Authors:  Piumi Y Liyanage; Sajini D Hettiarachchi; Yiqun Zhou; Allal Ouhtit; Elif S Seven; Cagri Y Oztan; Emrah Celik; Roger M Leblanc
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

2.  Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial.

Authors:  Roberta Caputo; Alessandra Fabi; Emanuela Romagnoli; Editta Baldini; Donatella Grasso; Nicola Fenderico; Andrea Michelotti
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-10-18

3.  Invasive ductal breast carcinoma underneath a lipoma in a male patient.

Authors:  James Landero; Khasha Touloei; Bradley P Glick
Journal:  J Clin Aesthet Dermatol       Date:  2012-10

4.  ADVANCED, RECURRENT, INVASIVE CRIBIFORM CARCINOMA OF THE BREAST IN A 17-YEAR-OLD MALE: A CASE REPORT.

Authors:  M E Aghahowa; I K Salu; K N Ezike; O S Bassey; M U Umar; O A Etim; I A Okwudire-Ejeh
Journal:  J West Afr Coll Surg       Date:  2018 Oct-Dec

5.  Debunk the myths: oncologic misconceptions.

Authors:  Jaydip Biswas
Journal:  Indian J Med Res       Date:  2014-02       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.